Academic Career Development in Pediatric Diabetes(K12)

描述（由申请人提供）： 这是响应RFA-DK-02-024的新申请，用于在匹兹堡大学匹兹堡儿童医院（CHP）建立NIH支持的儿科糖尿病初级教师职业发展计划，以补充T32奖学金培训申请。随着我们迎来了一个基础科学能力和转化探索的新时代，报销减少和临床创收需求增加使得年轻教师越来越难以“启动”学术生涯。因此，该计划的目的是培养下一代临床科学家，从事儿科糖尿病的独立学术事业，强调基础科学进步的临床应用。 该计划的核心组成部分是：1）与学术上成功的导师学徒; 2）根据具体的研究和教育需求为每个初级教师量身定制的高级课程工作和教学研究; 3）接触广泛的跨学科糖尿病研究研讨会; 4）核心研究和学术生存技能的发展; 5）密切跟进和指导教师的进步;（6）走向独立的学术生涯。培训计划的组织结构包括：1）项目主任，席尔瓦阿尔斯拉尼安医学博士，他是儿科综合临床研究中心的主任; 2）项目联合主任，Massimo Trucco医学博士，谁是在卫生防护中心和大学的JDRF中心补助金主任; 3）咨询委员会，由五个不同的研究轨道在糖尿病的副主任组成; 4）初级教师委员会，定制设计为每个K12任命;和5）外部咨询委员会3高度成就的糖尿病研究人员。从有前途的年轻教师池，从内部（T32计划的毕业生）或没有CHP，每年将资助两个。委员会会经审慎考虑及咨询委员会推荐后作出委任。特别考虑从少数民族人口中招聘和留住初级教师。获奖者将在1-2年的时间内将80%的时间用于研究。计划中的K12项目将吸引、发展和留住糖尿病儿科科学家，他们将在独立资助方面具有竞争力，并最终为未来一代的年轻研究人员组建一批高级教师导师。

DESCRIPTION (provided by applicant): This is a new application in response to RFA-DK-02-024 for the establishment of a NIH-supported junior faculty career development program in pediatric diabetes at the Children's Hospital of Pittsburgh (CHP), University of Pittsburgh, to complement the T32 Fellowship Training application. As we usher in a new era of basic scientific capabilities and translational exploration, decreasing reimbursement and increased demands for clinical revenue generation have made it increasingly difficult for young faculty to "jump-start" an academic career. Therefore, the aim of this program is to train the next generation of clinician-scientists for independent academic careers in pediatric diabetes emphasizing the clinical application of basic science advances. The core components of this program are: 1) apprenticeship with an academically successful mentor; 2) individually tailored ADVANCED course work and didactic study for each junior faculty based upon specific research and educational needs; 3) exposure to a broad range of interdisciplinary diabetes research seminars; 4) development of core research and ACADEMIC SURVIVAL SKILLS; 5) close follow up and guidance of faculty progress; and 6) evolution towards an INDEPENDENT academic career. The organizational structure of the training program includes: 1) the Program Director, Silva Arslanian M.D., who is the Director of the pediatric General Clinical Research Center; 2) the Program Co-Director, Massimo Trucco M.D., who is the Director of the JDRF Center Grant at CHP and the University; 3) the ADVISORY committee, comprised of the Associate Directors of five different research tracks in diabetes; 4) the Junior Faculty Committee, custom designed for each K12 appointee; and 5) An External Advisory Board of 3 highly accomplished diabetes researchers. From a pool of promising young faculty, from within (graduates of the T32 program) or without the CHP, two will be funded each year. Appointment will be made after careful scrutiny, and recommendation by the Advisory Committee. Special consideration is given to recruiting and retaining junior faculty from minority populations. Awardees will spend 80% of their time in research over a 1-2 year period. The planned K12 program will enable the attraction, development, and retention of pediatric scientists in diabetes who will be competitive for independent funding and will eventually form a group of senior faculty mentors for the future generation of young investigators.